Skip to main content

Critical Care Reviews Newsletter

Newsletter 572  |  November 28th, 2022

Please support our work to share science

CCR23 Delegate Hotel Rates Are Now Available

Welcome to the 572nd Critical Care Reviews Newsletter, bringing you the best critical care research and open access articles from across the medical literature over the past seven days.

The highlights of this week's edition are randomised controlled trials on postextubation noninvasive ventilation with active humidification vs high-flow nasal cannula & nebulized versus intravenous tranexamic acid for hemoptysis; systematic reviews and meta analyses on higher blood pressure versus normotension targets to prevent acute kidney injury & hypertonic saline for traumatic brain injury; and observational studies on the global mortality associated with 33 bacterial pathogens in 2019 & a substudy from the COCA trial, investigating the effect of calcium in patients with pulseless electrical activity and electrocardiographic characteristics potentially associated with hyperkalemia and ischemia. There are also guidelines on hypertensive crises & the prevention of alcohol withdrawal syndrome in the surgical ICU; plus narrative reviews on temperature control after cardiac arrest & posthepatectomy liver failure.

If you only have time to read one review article this week, try this one on lessons learned in mechanical ventilation/oxygen support in COVID19.

Support CCR

You can support Critical Care Reviews, from as little as the price of a cup of coffee per month or make a one-off donation. We are not-for-profit and make all our content free to view. Our aim is to share science for the benefit of all - please join us in this mission.

Research

Randomised Controlled Trials

Systematic Review & Meta Analyses

Observational Studies

Reviews

Clinical

COVID-19
Circulatory
Respiratory
Gastrointestinal
Hepatobiliary
Renal
Sepsis
Toxicology
Obstetrics
Miscellaneous

Clinics in Chest Medicine series on COVID-19

I hope you find this newsletter useful.


Until next week

Rob